The board and senior executives have obviously conceded either they're are out of their depth or have exhausted what they can do in terms of gaining more value for shareholders than what the acquirer is offering and two big shareholders have agreed from the looks of it!
- Forums
- ASX - By Stock
- MYX
- Ann: Mayne Pharma enters Scheme Implementation Deed with Cosette
MYX
mayne pharma group limited
Add to My Watchlist
1.15%
!
$5.28

Ann: Mayne Pharma enters Scheme Implementation Deed with Cosette, page-101
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.28 |
Change
0.060(1.15%) |
Mkt cap ! $430.1M |
Open | High | Low | Value | Volume |
$5.29 | $5.33 | $5.15 | $259.1K | 49.14K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 589 | $5.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.29 | 37 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 391 | 5.270 |
5 | 2066 | 5.260 |
4 | 7296 | 5.250 |
2 | 477 | 5.240 |
1 | 50 | 5.230 |
Price($) | Vol. | No. |
---|---|---|
5.300 | 2050 | 5 |
5.310 | 2363 | 9 |
5.320 | 451 | 2 |
5.330 | 452 | 3 |
5.340 | 8950 | 8 |
Last trade - 13.28pm 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online